Knights of Columbus Asset Advisors LLC Purchases 10,763 Shares of InMode Ltd. (NASDAQ:INMD)

Knights of Columbus Asset Advisors LLC grew its position in shares of InMode Ltd. (NASDAQ:INMDFree Report) by 12.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,700 shares of the healthcare company’s stock after purchasing an additional 10,763 shares during the quarter. Knights of Columbus Asset Advisors LLC owned about 0.12% of InMode worth $3,067,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Congress Asset Management Co. MA raised its holdings in InMode by 23.9% during the 3rd quarter. Congress Asset Management Co. MA now owns 862,871 shares of the healthcare company’s stock worth $26,283,000 after purchasing an additional 166,437 shares during the last quarter. Teacher Retirement System of Texas bought a new position in InMode during the 3rd quarter worth approximately $962,000. AlphaMark Advisors LLC bought a new position in InMode during the 3rd quarter worth approximately $189,000. Yelin Lapidot Holdings Management Ltd. bought a new position in InMode during the 3rd quarter worth approximately $7,535,000. Finally, Congress Wealth Management LLC DE raised its holdings in InMode by 6.1% during the 3rd quarter. Congress Wealth Management LLC DE now owns 128,462 shares of the healthcare company’s stock worth $3,913,000 after purchasing an additional 7,387 shares during the last quarter. Institutional investors own 65.49% of the company’s stock.

Wall Street Analyst Weigh In

INMD has been the subject of several analyst reports. Canaccord Genuity Group restated a “hold” rating and set a $22.00 price target on shares of InMode in a report on Thursday, December 7th. Barclays reduced their price objective on shares of InMode from $45.00 to $33.00 and set an “overweight” rating for the company in a research report on Thursday, January 4th. Canaccord Genuity Group downgraded shares of InMode from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $55.00 to $22.00 in a research report on Friday, October 13th. UBS Group reaffirmed a “neutral” rating and set a $24.00 price objective (down previously from $52.00) on shares of InMode in a research report on Friday, November 3rd. Finally, TheStreet downgraded shares of InMode from a “b-” rating to a “c+” rating in a research report on Thursday, October 19th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $37.00.

Read Our Latest Stock Analysis on InMode

InMode Trading Up 1.4 %

NASDAQ INMD opened at $21.88 on Thursday. The company has a market cap of $1.82 billion, a P/E ratio of 10.42 and a beta of 2.22. InMode Ltd. has a 12-month low of $18.57 and a 12-month high of $48.25. The company has a fifty day simple moving average of $22.11 and a 200 day simple moving average of $30.00.

InMode (NASDAQ:INMDGet Free Report) last released its earnings results on Thursday, November 2nd. The healthcare company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.01. InMode had a return on equity of 31.72% and a net margin of 36.18%. The company had revenue of $123.11 million for the quarter, compared to analysts’ expectations of $123.00 million. Sell-side analysts predict that InMode Ltd. will post 2.19 EPS for the current year.

InMode Profile

(Free Report)

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.

Featured Articles

Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. (NASDAQ:INMDFree Report).

Institutional Ownership by Quarter for InMode (NASDAQ:INMD)

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.